Table 1.

Eligibility criteria for studies assessing the effect of non-pharmacological self-management interventions on chemotherapy-induced peripheral neuropathy symptoms and related outcomes in people with advanced cancer.

	Inclusion Criteria	Exclusion Criteria
Population	Advanced cancer: any solid tumor with locally or systemically advanced disease stage (UICC TNM stage III–IV) [26] or any hematological cancer 1 Undergoing or have undergone chemotherapy Any age (i.e., adults and children)	Studies including people at any cancer stage where results have not been reported separately for those with advanced cancer
Intervention	Any non-pharmacological self-management intervention administered by the person with cancer or their caregiver (e.g., exercise, oral nutrition supplements, massage, thermal therapies, meditation), including those initiated with support from a health professional	Pharmacological interventions (e.g., prescribed and non-prescribed medications) Eligible non-pharmacological interventions administered in conjunction with pharmacological interventions for CIPN (e.g., duloxetine, gabapentin, pregabalin, carbamazepine, amitriptyline) Non-pharmacological interventions not administered by the person with cancer (e.g., acupuncture, electrical nerve stimulation, scrambler therapy, moxibustion, reflexology, intravenous vitamins)
Comparator	Any control (e.g., placebo, usual care)
Outcomes	Incidence or severity of CIPN symptoms as measured by any tool
Study design	Randomized controlled parallel trials Published in peer-reviewed journals	Conference abstracts only Non-randomized controlled trials Narrative/systematic reviews, qualitative studies, protocols, case studies, observational studies
Language	English or able to be translated into English

UICC TNM: The Union for International Cancer Control Tumor, Nodes, and Metastases Classification of Malignant Tumors. ¹ Studies that referred to ‘advanced cancer’ but do not specify the stage and/or type of cancer were eligible for inclusion.